Trials / Withdrawn
WithdrawnNCT02065778
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke
A Clinical Study of Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with chronic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous bone marrow mononuclear cell transplantation | bone marrow derived mononuclear cells are administered intrathecally in chronic stroke patients |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2013-07-01
- Completion
- 2014-01-01
- First posted
- 2014-02-19
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02065778. Inclusion in this directory is not an endorsement.